Psychologic outcomes of dermatological diseases and comorbidities;Deri hastaliklarinin psikojenik sonuçlari ve komorbiditeler

Turkderm Deri Hastaliklari ve Frengi Arsivi

Volumn 44, Issue SUPPL. 1, 2010, Pages 25-35

  Mercan, Sibel ^a  

^a SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Anxiety disorder; Depression; Obsesive compulsive disorder; Obsesive compulsive spectrum disorder; Psychodermatology

Indexed keywords

ANXIETY DISORDER; CLINICAL EVALUATION; COMORBIDITY; DEPRESSION; DERMATOLOGY; HUMAN; MENTAL DISEASE; OUTCOME ASSESSMENT; PSYCHOBIOLOGY; PSYCHOLOGY; REVIEW; SKIN DISEASE; SOCIAL PSYCHOLOGY; SOMATIZATION;

EID: 79551491733     PISSN: 1019214X     EISSN: None     Source Type: Journal    
DOI: 10.4274/turkderm.s44.25     Document Type: Review

References (108)

1. Harth W, Gieler U, Kusnir D, Tausk FA: Clinical management in psychodermatology. Berlin, Springer- Verlag Berlin Heidelberg sf:123-30.
2. Öztürk MO, Uluşahin A: Duygudurum bozukluklari, Ruh Saǧliǧi ve Bozukluklari. Cilt I, Nova Danişmanlik, Yayincilik, Ankara. 2008;337-427.
3. Sadock BJ, Sadock VA: Mood disorders. In Kaplan & Sadock's Synopsis of Psychiatry, 10.th ed. Lippincott Williams and Wilkins, Philadelphia. 2007;527-78.
4. Mutasim DF, Adams BB: The psychiatric profile of patients with psychogenic excoriation. J Am Acad Dermatol 2009;61:611-3.
5. Sharma V, Corpse C: Lithium treatment of trichotillomania with comorbid bipolar II disorder. Arch Womens Ment Health. 2008;11:305-6.
6. Hamiel D, Yoffe A, Roe D: Trichotillomania and the mourning process: a case report and review of the psychodynamics. Isr J Psychiatry Relat Sci 36:192-9; discussion 200-2.
7. Jafferany M: Lithium and psoriasis: what primary care and family physicians should know. Prim Care Companion J Clin Psychiatry 2008;10:435-9.
8. Gupta AK, Knowles SR, Gupta MA, Jaunkalns R, Shear NH: Lithium therapy associated with hidradenitis suppurativa: case report and a review of the dermatologic side effects of lithium. J Am Acad Dermatol 1995;32:382-6.
9. Aithal V, Appaih P: Lithium induced hidradenitis suppurativa and acne conglobata. Indian J Dermatol Venereol Leprol 2004;70:307-9.
10. Varghese SP, Haith LR, Patton ML, Guilday RE, Ackerman BH: Lamotrigine-induced toxic epidermal necrolysis in three patients treated for bipolar disorder. Pharmacotherapy 2006;26:699-704. (Pubitemid 43673053)
11. Chang CC, Shiah IS, Chang HA, Huang SY: Toxic epidermal necrolysis with combination lamotrigine and valproate in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:147-50.
12. Czajkowski R, Weiss-Rostkowska V, Wankiewicz A, Drewa T, Placek W, Biedka M et al: Stevens-Johnson syndrome induced by carbamazepine. Acta Pol Pharm 2007;64:89-92.
13. Kocak S, Girisgin SA, Gul M, Cander B, Kaya H, Kaya E: Stevens-Johnson syndrome due to concomitant use of lamotrigine and valproic acid. Am J Clin Dermatol 2007;8:107-11. (Pubitemid 46998554)
14. Mercke Y, Sheng H, Khan T, Lippmann S: Hair loss in psychopharmacology. Ann Clin Psychiatry 2000;12:35-42.
15. Gerstner T, Lipinski C, Longin E, König S: Valproate-induced change in hair color. J Am Acad Dermatol 2008;58:63-4.
16. Wilting I, van Laarhoven JH, de Koning-Verest IF, Egberts AC: Valproic acid-induced hair-texture changes in a white woman. Epilepsia 2007;48:400-1. (Pubitemid 46213898)
17. Gupta MA, Gupta AK: Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management. Am J Clin Dermatol 2003;4:833-42.
18. Picardi A, Abeni D, Renzi C, Braga M, Melchi CF, Pasquini P: Treatment outcome and incidence of psychiatric disorders in dermatological out-patients. J Eur Acad Dermatol Venereol 2003;17:155-9. (Pubitemid 36416780)
19. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSMIII-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19.
20. Katon W, Schulberg H. Epidemiology of depression in primary care. Gen Hosp Psychiatry 1992;14:237-47.
21. Regier DA, Boyd JH, Burke JD Jr, Rae DS, Myers JK, Kramer M et al: One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites. Arch Gen Psychiatry 1988;45:977-86.
22. Picardi A, Abeni D, Mazzotti E, Fassone G, Lega I, Ramieri L et al: Screening for psychiatric disorders in patients with skin diseases: a performance study of the 12-item General Health Questionnaire. J Psychosom Res 2004;57:219-23. (Pubitemid 39422756)
23. Picardi A, Amerio P, Baliva G, Barbieri C, Teofoli P, Bolli S et al: Recognition of depressive and anxiety disorders in dermatological outpatients. Acta Derm Venereol 2004;84:213-7. (Pubitemid 38649399)
24. Arnon D. Cohen, Andr'e Ofek-Shlomai, Daniel A: Vardy, Zeev Weiner, Pesach Shvartzman Depression in dermatological patients identified by the Mini International Neuropsychiatric Interview questionnaire. Journal of the American Academy of Dermatology 2006;54:94-9.
25. Sampogna F, Picardi A, Chren MM, Melchi CF, Pasquini P, Masini C et al: Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions. Psychosom Med 2004;66:620-4. (Pubitemid 38971260)
26. Gupta MA: Psychiatric comorbidity in dermatological disorders (eds). Walker C, Papadopoulos L. In Psychodermatology, Oxford University Press, New York, 2005;30-4.
27. R. Fried, M. Gupta, A. Gupta: Depression and Skin Disease Dermatologic Clinics, 2005;23:657-64.
28. Stahl SM, Essential Psychopharmacology, Neuroscientific Basis and Practical Applications. Cambridge University Pres, UK, 2000;135-98.
29. Duman RS: Introduction: theories of depression from monoamines to neuroplasticity. In Olei JP, Costa E Silva JA, Macher JP (ed). Neuroplasiticity: A New Approach to the Pathology of Depression. Current Medicine Group, London, 2004;6-10.
30. Gershon ES, Hamovit J, Guroff I: A familial study of schizoaffective, bipolar I, bipolar II, unipolar and normal control probands. Arc Gen Psychiatry 1982;39:1157-67. (Pubitemid 12034170)
31. Preskorn SH. Outpatient management of depression. Wichita: Professional communications, 1994;28.
32. Krueger DW: Body Self and Psychological Self. New York: Brunner/ Mazel, 1989:3-31.
33. Heim C, Newport DJ, Mletzko T, Miller AH, Nemeroff CB: The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology 2008;33:693-710.
34. American Psychiatric Association, Diagnostic and statistical manual of mental disorders (4th ed.), American Psychiatric Association, Washington (DC) (1994).
35. Kirli S: Depresyon. Bursa Psikiyatri ve Sanat Yayinevi, 2002;46-8.
36. Andreasen NC, Black DW: Introductory textbook of Psychiatry. Washington DC, American Psychiatric Publishing 2001, 303-304.
37. Gupta MA, Gupta AK, Haberman HF. Neurotic excoriations: a review and some new perspectives. Compr Psychiatry 1986;27:381-6.
38. Gupta MA, Gupta AK. Psychocutenous Medicine. Ed. Koo JYM, Lee CS. Marcel Dekker AG, NY, 2003;233-49.
39. Margueling AL, Zane LT. Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. : Semin Cutan Med Surg. 2007 Dec;26(4):210-20.
40. Cimilli C. Kortikosteroidler ve Davranifl. PsychoMed 1996;2:5-12.
41. Gupta MA, Gupta AK, Wateel GN, Watteel GN: Perceived depreivation of social touch in psoriasis is associated with greater psychological morbidity: an index of the stigma experience in dermatological disorders. Cutis 1998;61:339-44.
42. Gupta MA, Gupta AK, Schork NJ, Ellis CN: Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosom Medicine 1994, 56:36-40.
43. Gupta MA, Gupta AK, Kirkby S, Weiner HK, Mace TM, Shork NJet al: Pruritus in psoriasis: a prospective study of some psychiatric and dermatological correlates. Arch Dermatol 1988;124:1052-7.
44. Gupta MA, Gupta AK. Depression and social ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998;139:846-50.
45. Colon EA, Popkin MK, Callies AL, Dessert NJ: Lifetime prevelance of psychiatric disorders in patients with alopecia areata. Compr Psychiatry 1991;32:245-51.
46. Koo JM, Shellow WV, Hallman CP, Edwards JE. Alopecia areata and increased prevelance of psychiatric disorders. Int J Dermatol 1994;33:849-50.
47. Sadock BJ, Sadock VA: Kaplan and Sadock's Synopsis of Psychiatry. 10th Edition. Philadelphia. Lippincott Williams and Wilkins, 2007; 579-627.
48. Freud, A: The ego and the mechanism of defence. The writings of Anna Freud, (Vol. II), New York: International Universities Press, 1966, USA.
49. Hettema JM, Prescott CA, Myers JM, Neale MC, Kendler KS: The structure of genetic and environmental risk factors for anxiety disorders in men and women. Arch Gen Psychiatry 2005;62:182-9.
50. Charney DS: Anxiety Disorders: Introduction and overview. Kaplan and Sadock's Comprehensive Textbook of Psychiatry. 8th Edition. Ed. Sadock BJ, Sadock VA. Philadelphia, Lippincott Williams and Wilkins, 2005;1718.
51. Woodruff PWR, Higgins EM, Vivier AWP, Wessely S: Psychiatric illness in patients referred to a dermatology-psychiatry clinic 1997. Gen Hosp Psychiatry 1997;19:29-35.
52. Vargas Laguna E, Peña Payero ML, Vargas Márquez A: Influence of anxiety in diverse cutaneous diseases. Actas Dermosifiliogr 2006;97:637-43.
53. Koo JY, Smith LL: Obsessive-compulsive disorders in the pediatric dermatology practice. Pediatr Dermatol 1991;8:107-13.
54. Fineberg NA, O'Doherty C, Rajagopal S, Reddy K, Banks A, Gale TM: How common is obsessive-compulsive disorder in a dermatology outpatient clinic. J Clin Psychiatry 2003;64:152-5. (Pubitemid 36268317)
55. Demet MM. Deveci A. Taskin EO. Ermertcan AT. Yurtsever F. Deniz F et al: Obsessive-compulsive disorder in a dermatology outpatient clinic. Gen Hosp Psychiatry 2005;27:426-30. (Pubitemid 41566069)
56. Simeon D, Stein DJ, Hollander E: Depersonalization disorder and self injurious behaviour. J Clin Psychiatry 1995;56:36-9.
57. Lipinski JF: Clomipramine in the treatment of self mutilating behaviours. N Eng J Med 1991;324:1441.
58. Hofer, M: Hidden regulators: Implications for a new understanding of attachment, separation, and loss. Attachment theory: Social, developmental, and clinical perspectives In Ed. Goldberg S, Muir R, Kerr J. Hillsdale, NJ: The Analytic Press 1995;203-30.
59. Farber, S: When the body is the target: Self-harm, pain, and traumatic attachments. Northvale, NJ: Jason Aronson 2000.
60. Sachs, A: The many acts of self-harm: An act of multiplicity and dissociation. Child Mental Clin Soc Work J 2008;36:63-72.
61. Bromberg, P: Standing in the spaces: Essays on clinical process, trauma, and dissociation. Hillsdale, NJ/London: The Analytic Press 1998.
62. Snorrason I, Smári J, Olafsson RP: Emotion regulation in pathological skin picking: Findings from a non-treatment seeking sample. J Behav Ther Exp Psychiatry 2010 Feb 6. [Epub ahead of print].
63. Odlaug BL, Grant JE: Clinical characteristics and medical complications of pathologic skin picking. Gen Hosp Psychiatry 2008;30:61-6.
64. Grant JE, Odlaug BL: Update on pathological skin picking. Curr Psychiatry Rep 2009;11:283-8.
65. Panconesi E, Cossidente A, Giorgini S: A psychosomatic approach to dermatologic cosmetology. Int J Dermatol 1983;22:449-54.
66. Jowett S, Ryan T: Skin disease and handicap: an analysis of the impact of skin conditions. Soc Sci Med 1985;20:425-9.
67. Motley RJ, Finlay AY: How much disability is caused by acne? Clin Exp Dermatol 1989;14:194-8.
68. Stein DJ, Mullen L, Islam MN, Cohen L, DeCaria CM, Hollander E: Compulsive and impulsive symptomatology in trichotillomania. Psychopathology 1995;28:208-13.
69. Stanley MA, Swann AC, Bowers TC: A comparison of clinical features in trichotillomania and obsessive copmulsive disorder. Behav Res Ther 1992;30:39-44.
70. Reeve EA, Bernstein GA, Christenson GA: Clinical characteristics and psychiatric comorbidity in children with trichotillomania. J Am Acad Child Adolesc Psychiatry 1992;31:132-8.
71. Hollander E, Kim S, Braun A, Simeon D, Zohar: Cross-cutting issues and future directions for the OCD spectrum. Psychiatry Res 2009;30;170.
72. McElroy SL, Phillips KA, Keck P: Obsessive compulsive spectrum disorder. J Clin Psychiatry 1994;55:33-53.
73. Corso KA, McGeary DD: Trichotillomania and post-traumatic stress disorder: a case study. Mil Med 2008;173:1136-41.
74. Lochner C, Seedat S, Stein DJ: Chronic hair-pulling: phenomenology-based subtypes. J Anxiety Disord 2010;24:196-202.
75. Mercan S, Altunay IK: Treatment of Trichotillomania. Research and Clinical Applications in Psychosomatic Dermatology Congress Book, Venice, 2009:40-1.
76. Christenson GA, Mackenzie TB, Mitchell JE: Characteristics of 60 adult chronic hair pullers. Am J Psychiatry 1991;148:365-70.
77. Gupta MA, Gupta AK, Haberman HF: The self inflicted dermatoses: a critical review. Gen Hosp Psychiatry 1987;9:45-52.
78. Muller SA, Winkelmann RK: Trichotillomania: a clinicopathologic study of 24 cases. Arch Dermatol 1972;105:535-40.
79. Neal-Barnett A, Flessner C, Franklin ME, Woods DW, Keuthen NJ, Stein DJ: Ethnic differences in trichotillomania: Phenomenology, interference, impairment, and treatment efficacy. Anxiety Disord 2010 Mar 31. [Epub ahead of print]
80. Pacan P, Grzesiak M, Reich A, Szepietowski JC: Onychophaniga as a spectrum of obsessive compulsive disorders. Acta Derm Venereol 2009;89:278-80.
81. Ghanizadeh A. Association of nail biting and psychiatric disorders in children and their parents in a psychiatrically referred sample of children. Child Adolesc Psychiatry Ment Health 2008;2:13.
82. Tanaka OM, Vitral RW, Tanaka GY, Guerrero AP, Camargo ES: Nailbiting, or onychophagia: a special habit. Am J Orthod Dentofacial Orthop 2008;134:305-8.
83. Köşlü A, Altunay İK: Deri ile ilgili Vücut İmaj Bozukluklari ve Dismorfofobi. Dermatolojide gelişmeler-3. Ed:Oǧuz O,Serdaroǧlu S. Doyuran matbaasi İstanbul,1998:151-8.
84. Vargel, S, Ulusahin A: Psychopathology and body image in cosmetic surgery patients. Aesthetic Plastic Surgery 2001;25:474-8.
85. Wilson JB, Arpey CJ: Body dysmorphic disorder: suggestions for detection and treatment in a surgical dermatology practice. Dermatol Surg 2004;30:1391-9.
86. Conrado LA: Body dysmorphic disorder in dermatology: diagnosis, epidemiology and clinical aspects. An Bras Dermatol 2009;84:569-81.
87. Cotterill JA: Body dysmorphic disorder. Dermatol Clin 1996;14:457-63.
88. Veale D: Body dysmorphic disorder. Postgrad Med J 2004;80:67-71.
89. Anderson RC: Body dysmorphic disorder: recognition and treatment. Plast Surg Nurs 2003;23:125-8.
90. Koblenzer CS: The dysmorphic syndrome. Arch Dermatol 1985;121:780-4.
91. Cotterill JA: Dermatological non-disease: a common and potentially fatal disturbance of cutaneous body image. Br J Dermatol 1981;104:611-9.
92. Oosthuizen P, Lambert T, Castle DJ: Dysmorphic concern: prevalence and associations with clinical variables. Austr N Zeal J Psychiatry 1998;32:129.
93. Kaymak Y, Taner E, Simflek I: Body dysmorphic disorder in university students with skin diseases compared with healthy controls. Acta Derm Venereol 2009;89:281-4.
94. Grant JE, Phillips KA: Recognizing and treating body dysmorphic disorder. Ann Clin Psychiatry 2005;17:205-10.
95. Phillips KA, Dufresne RG, Wilkel CS, Vittorio CC: Rate of body dysmorphic disorder in dermatology patients. J Am Acad Dermatol 2000;42:436-41.
96. Gupta MA, Johnson AM, Gupta AK: The development of acne quality of life scale: reliability, validity and relation to subjective acne severity in mild to moderate acne vulgaris. Acta Derm Venereol 1998;78: 451-6.
97. Gupta MA, Gupta AK, Chandarana PC, Johnson AM: Dissociative symptoms and self induced dermatoses: a preliminary empirical study. Psychosom Med 2000;62:116.
98. Gupta MA, Gupta AK, Ellis CN, Voorhees JJ: Bulimia Nervosa and acne may be related: a case report. Can J Psychiatry 2000;37:58-61.
99. Walker C, Papadopoulos L: Psychodermatology. Cambridge Press, New York 2005;29-39.
100. Picardi A, Porcelli P, Pasquini P, Fassone G, Mazzotti E, Lega I, Ramieri L, Sagoni E, Abeni D, Tiago A, Fava GA: Integration of multiple criteria for psychosomatic assessment of dermatological patients. Psychosomatics 2006;47:122-8.
101. Wittkowski A, Richards HL, Griffiths CE, Main CJ: The impact of psychological and clinical factors on quality of life in individuals with atopic dermatitis. Psychosom Res 2004;57:195-200.
102. Kent G, al-Abadie M: Factors affecting responses on Dermatology Life Quality Index items among vitiligo sufferers. Clin Exp Dermatol 1996;21:330-3.
103. Leary MR, Rapp SR, Herbst KC, Exum ML, Feldman SR: Interpersonal concerns and psychological difficulties of psoriasis patients: effects of disease severity and fear of negative evaluation. Health Psychol 1998;17:530-6.
104. Bessell A, Moss TP: Evaluating the effectiveness of psychosocial interventions for individuals with visible differences: a systematic review of the empirical literature. Body Image 2007;4:227-38.
105. Mason PJ: Vitiligo: the psychosocial effects. Medsurg Nurs 1997;6:216-8.
106. Porter JR, Beuf AH, Lerner AB: The effect of vitiligo on sexual relationships. J Am Acad Dermatol 1990;22:221-2.
107. Evren B, Evren C: Relationship Between Alexithymia and Social Anxiety in Female Outpatients with Dermatological Disorder Presenting for Psychiatric Consultation. J Clin Psychology in Medical Settings 2007;14:258-65.
108. Mercan S, Altunay IK: Psikiyatri ve dermatolojinin ortak çalişma alani: psikodermatoloji. Türk Psikiyatri Derg 2006;17:305-13.